Cargando…
Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients
Background: Several recent studies support the notion of excessive complement activation in patients with severe coronavirus disease-19 (COVID-19), with beneficial results of complement inhibition in case series. In this context, severe COVID-19 shares common characteristics with complement-mediated...
Autores principales: | Gavriilaki, Eleni, Kokoris, Styliani, Touloumenidou, Tasoula, Koravou, Evdoxia, Koutra, Maria, Karali, Vassiliki, Papalexandri, Lila, Chatzopoulou, Fani, Chatzidimitriou, Maria, Chatzidimitriou, Dimitrios, Veleni, Anastasia, Grigoriadis, Savvas, Konstantinidou, Eulampia, Chloros, Diamantis, Kioumis, Ioannis, Kaimakamis, Evaggelos, Bitzani, Milly, Boumpas, Dimitrios, Tsantes, Argyrios, Sotiropoulos, Damianos, Sakellari, Ioanna, Anagnostopoulos, Achilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330308/ http://dx.doi.org/10.1182/blood-2020-139304 |
Ejemplares similares
-
Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection
por: Tsiftsoglou, Stefanos A., et al.
Publicado: (2023) -
Genetic justification of severe COVID-19 using a rigorous algorithm
por: Gavriilaki, Eleni, et al.
Publicado: (2021) -
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
por: Asteris, Panagiotis G., et al.
Publicado: (2022) -
Humoral and T Cell Immune Responses to Sars-Cov-2 Vaccination in Hematopoietic Cell Transplant Recipients
por: Gavriilaki, Eleni, et al.
Publicado: (2021) -
Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients
por: Gavriilaki, Eleni, et al.
Publicado: (2022)